|
|
| Nasdaq Factor Dogs Opportunity, 4 |
FGMNAX |
8/9/2018 |
| 30309U421 |
| 30309U447 (Fee) |
|
| 30309U439 |
| 30309U454 (Fee) |
|
15 Month |
|
|
| American Agenda, 6 |
FHCBRX |
8/10/2018 |
| 30309U546 |
| 30309U561 (Fee) |
|
| 30309U553 |
| 30309U579 (Fee) |
|
2 Year |
|
|
| Deep Value Dividend, 20 |
FDLQVX |
8/10/2018 |
| 30309U348 |
| 30309U363 (Fee) |
|
| 30309U355 |
| 30309U371 (Fee) |
|
2 Year |
|
|
| Dow® Target 10, August 2018 |
FWEKLX |
8/10/2018 |
| 30309Q305 |
| 30309Q321 (Fee) |
|
| 30309Q313 |
| 30309Q339 (Fee) |
|
13 Month |
|
|
| Equity Income Select, 58 |
FRHJNX |
8/10/2018 |
| 30309U306 |
| 30309U322 (Fee) |
|
| 30309U314 |
| 30309U330 (Fee) |
|
2 Year |
|
|
| Diversified Income & Growth, Fall 2018 |
FOHGZX |
8/13/2018 |
| 30309R600 |
| 30309R626 (Fee) |
|
| 30309R618 |
| 30309R634 (Fee) |
|
5 Year |
|
|
| Election Portfolio, 2016 Series 8 |
FPHAMX |
8/13/2018 |
| 30309R568 |
| 30309R584 (Fee) |
|
| 30309R576 |
| 30309R592 (Fee) |
|
15 Month |
|
|
| ESG Impact Opportunity, 4 |
FDIFAX |
8/13/2018 |
| 30309U587 |
| 30309U603 (Fee) |
|
| 30309U595 |
| 30309U611 (Fee) |
|
15 Month |
|
|
| Strategic Income Advantage Select Closed-End, 77 |
FWCIEX |
8/13/2018 |
| 30309V767 |
| 30309V783 (Fee) |
|
| 30309V775 |
| 30309V791 (Fee) |
|
2 Year |
|
|
| Corporate Investment Grade, 3-7 Year, 5 |
FJSIPX |
8/14/2018 |
| 30309V189 |
| 30309V197 (Wrap) |
|
|
TBD |
|
|
| Global Dividend, 56 |
FMRCLX |
8/15/2018 |
| 30309U629 |
| 30309U645 (Fee) |
|
| 30309U637 |
| 30309U652 (Fee) |
|
2 Year |
|
|
| SMid High Dividend, 31 |
FQABVX |
8/15/2018 |
| 30309U660 |
| 30309U686 (Fee) |
|
| 30309U678 |
| 30309U694 (Fee) |
|
2 Year |
|
|
| Equity Income, 61 |
FYEHMX |
8/16/2018 |
| 30309U785 |
| 30309U801 (Fee) |
|
| 30309U793 |
| 30309U819 (Fee) |
|
5 Year |
|
|
| Balanced Income, 63 |
FZWDNX |
8/17/2018 |
| 30309V247 |
| 30309V262 (Fee) |
|
| 30309V254 |
| 30309V270 (Fee) |
|
5 Year |
|
|
| Sabrient Rising Rate, 9 |
FNICLX |
8/17/2018 |
| 30309U702 |
| 30309U728 (Fee) |
|
| 30309U710 |
| 30309U736 (Fee) |
|
2 Year |
|
|
| SMid Biotechnology, 3 |
FRDSKX |
8/17/2018 |
| 30309U744 |
| 30309U769 (Fee) |
|
| 30309U751 |
| 30309U777 (Fee) |
|
15 Month |
|
|